Skip to main content

Day: January 5, 2021

Proofpoint to Report Fourth Quarter and Full Year 2020 Financial Results

SUNNYVALE, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) — Proofpoint, Inc., (NASDAQ: PFPT), a leading cybersecurity and compliance company, today announced it will issue a press release reporting financial results for the fourth quarter and full year ended December 31, 2020, after the close of the market on February 4, 2021.Proofpoint will host a conference call and live webcast to discuss those financial results for investors and analysts at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on February 4, 2021. To access the conference call, dial (800) 458-4121 for the U.S. or Canada and (929) 477-0324 for international callers with conference ID #8267322. The webcast will be available live on the Investors section of the company’s website at investors.proofpoint.com. An audio replay of the call will also be available beginning at...

Continue reading

Freshpet, Inc. to Participate in the 2021 ICR Conference

SECAUCUS, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) — Freshpet, Inc. (“Freshpet” or the “Company”) (NASDAQ:FRPT) today announced that members of the executive management team will participate in the virtual 2021 ICR Conference.The presentation will be on Wednesday, January 13 at 10:30 a.m. ET and can be accessed over the Internet and hosted on the “Investors” section of the Company’s website at www.freshpet.com. An accompanying presentation will be posted before market open.About FreshpetFreshpet’s mission is to improve the lives of dogs and cats through the power of fresh, real food. Freshpet foods are blends of fresh meats, vegetables and fruits farmed locally and made at our Kitchens in Bethlehem PA.  We thoughtfully prepare our foods using natural ingredients, cooking them in small batches at lower temperatures...

Continue reading

Aeterna Zentaris to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference

CHARLESTON, S.C., Jan. 05, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that Dr. Klaus Paulini, Chief Executive Officer of Aeterna, will present at the H.C. Wainwright BioConnect 2021 Virtual Conference taking place January 11-14, 2021.The video webcast presentation will be available for viewing on-demand beginning Monday, January 11, 2021, at 6:00 AM ET for those registered for the event and will be accessible on the Events page in the Investors section of the Company’s website (www.zentaris.com).For more information about the event, please visit the conference website here.About Aeterna Zentaris Inc.Aeterna Zentaris Inc. is a specialty biopharmaceutical company commercializing...

Continue reading

Mondelēz International Acquires Hu, A Well-being Snacking Company

Premium, well-being brand platform founded on simple ingredients, provides cross-category growth opportunities in snackingTransaction follows April 2019 minority investment through SnackFutures innovation hubCHICAGO, Jan. 05, 2021 (GLOBE NEWSWIRE) — Mondelēz International (NASDAQ: MDLZ) today announced it has acquired Hu (as in “Human”) Master Holdings, the parent company of Hu Products, a fast-growing US-based snacking company offering high-quality snacks made from simple ingredients.Hu, which comes from the phrase “Get Back to Human”, is a purpose-led lifestyle brand with a devoted fan base. Founded in 2012 as a family business by Jason H. Karp and siblings Jordan Brown and Jessica (Brown) Karp, Hu began as Hu Kitchen in New York City, a high-end restaurant and market focused on delicious foods with simple, real ingredients. The...

Continue reading

Trinity Biotech Announces CE Mark of its Covid-19 IgG ELISA Antibody Test

DUBLIN, Ireland, Jan. 05, 2021 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB) has achieved CE Mark approval and registration for its Covid-19 IgG ELISA antibody test, the Captia™ SARS-CoV-2 IgG ELISA.  Trinity Biotech has launched the test in countries throughout the European Union as well as other countries that recognise the CE Mark designation. This is in addition to our launch of the product in the US following submission under the FDAs Emergency Use Authorisation pathway.Test OverviewThe test uses a recombinant form of coronavirus spike protein to detect IgG antibodies which are the focus for SARS-CoV-2 vaccine development. The detection of IgG antibodies indicates either past exposure to the virus or the desired immune response following vaccination.Trinity Biotech expects that the antibody test will have a number of...

Continue reading

Bel Fuse Appoints Farouq Tuweiq, Former Investment Banker, as Chief Financial Officer

JERSEY CITY, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) — Bel Fuse Inc. (“Bel,” or, “the Company”) (Nasdaq:BELFA and Nasdaq:BELFB), a leading supplier of products that power, protect and connect electronic circuits, today announced that Farouq Tuweiq has been named Chief Financial Officer of Bel Fuse Inc., effective February 15, 2021.Daniel Bernstein, Chief Executive Officer of Bel commented, “Farouq is a skilled senior professional with a unique background in acquisitions, capital markets, finance, and accounting that will greatly enhance our ability to accelerate and execute our growth strategy. He will be keenly focused on various pathways to unlock and create shareholder value both organic and inorganic. We have made the commitment to Farouq knowing that our entire organization and stakeholders will be well-served by adding the energy,...

Continue reading

Daseke Announces Cooperation Agreements with Lyons Capital and Don Daseke

Appoints Grant Garbers to Board of DirectorsCompany to Repurchase Three Million Shares of StockADDISON, Texas, Jan. 05, 2021 (GLOBE NEWSWIRE) — Daseke, Inc. (NASDAQ: DSKE) (“Daseke” or the “Company”), the largest flatbed, specialized transportation and logistics solutions company in North America, announced today that it reached separate agreements with Lyons Capital, LLC and its affiliates (together “Lyons Capital”), who hold approximately 5% of the Company’s common stock, and with Don Daseke and his affiliates (together, “Mr. Daseke”), who hold approximately 28% of the Company’s common stock, regarding the membership and composition of the Board of Directors of the Company (the “Board”).Under the terms of the agreement with Lyons Capital, the Company appointed Grant Garbers to its Board, effective January 1, 2021, and will nominate...

Continue reading

Stryker acquires OrthoSensor

Kalamazoo, Michigan, Jan. 05, 2021 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced today the acquisition of OrthoSensor, Inc., a privately held company founded in 2007 and headquartered in Dania Beach, FL. OrthoSensor, Inc., is a leader in the digital evolution of musculoskeletal care and sensor technology for total joint replacement.“Smart devices and implants will play a big role in orthopaedics and we are excited for OrthoSensor to join Stryker as we continue to innovate and advance smart sensor technologies, including intraoperative sensors, wearables and smart implants across our joint replacement business,” said Spencer Stiles, Stryker’s Group President, Orthopaedics and Spine. “Patient recovery will become more active as real-time measurement on key performance insights drive improved outcomes and patient satisfaction.”OrthoSensor...

Continue reading

SEEDO FLOAT IT’S SUBSIDIARY AT A NIS 20 MILLION VALUATION

TEL AVIV, Jan. 05, 2021 (GLOBE NEWSWIRE) — Seedo Corp. (OTC: SEDO) (“Seedo” or the “Company”) is pleased to provide the following business announced todayThe Company, through its recently formed Israeli subsidiary, Saffron-Tech Ltd. (“Saffron Tech”), plans to roll out its proof of concept in the coming months. This technology will provide turnkey automated growing containers for high-quality, high-yield saffron all year round. The Company is in advanced stages of developing and testing a fully automated and remotely managed system for growing high-quality, high-yield saffron anywhere and anytime.The Company’s technology offers a controlled environment based on the Company’s deep knowledge in plant biology. The technology provides optimal conditions for each stage of the plant’s development to reach optimal product quality.  The...

Continue reading

Penn Virginia Announces Management Changes

HOUSTON, Jan. 05, 2021 (GLOBE NEWSWIRE) — Penn Virginia Corporation (“Penn Virginia” or the “Company”) (NASDAQ:PVAC) today announced the departure of Benjamin A. Mathis, Senior Vice President, Operations & Engineering, effective January 4, 2021.“On behalf of the entire Company, we want to thank Ben for his years of hard work and commitment to Penn Virginia,” said Darrin Henke, President and Chief Executive Officer of Penn Virginia. “He has taken Penn Virginia’s drilling and completion program to the next level and positioned us well for the future. He has been a tremendous asset to Penn Virginia, and we wish him the best in his future endeavors.”Separately, the Company also announced that it had appointed Julia Gwaltney as its new Senior Vice President, Development, effective January 5, 2021. In this position, Ms. Gwaltney...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.